Clinical Trials Directory

Trials / Unknown

UnknownNCT05257369

Broad Band Emission LED Phototherapy Source Versus Narrow Band

Clinical Efficacy of LED Phototherapy Devices With Blue - Green Versus Blue Light of Equal Irradiance in Neonates With Non Hemolytic Jaundice

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
110 (estimated)
Sponsor
Erebouni Medical Center · Academic / Other
Sex
All
Age
24 Hours – 14 Days
Healthy volunteers
Not accepted

Summary

Phototherapy is the most frequently used treatment in neonatology when serum bilirubin levels exceed physiological limits. Light-emitting diodes (LEDs) are become routinely used for phototherapy in neonates with hyperbilirubinemia. Blue LED light with peak emission around 460 nm is regarded as the most suitable light sources for phototherapy and they recommended by most neonatal guidelines. However, the effectiveness of phototherapy with narrow-band LED light sources can be increased by expanding the spectral range of incident radiation within the absorption of bilirubin due to the strongly marked heterogeneity absorption properties of bilirubin in a different microenvironment. Longer wavelength light, such as green light, is expected to penetrate the infant's skin deeper. It is still controversial whether the use of green light has any advantage over blue light. The most effective and safest light source and the optimal method to evaluate phototherapy, however, remain unknown.The aim of this study was to compare, at equal light irradiance, the clinical efficacy of broad spectrum blue- green LED with blue narrow spectral band phototherapy device.

Conditions

Interventions

TypeNameDescription
DEVICEBlue-Green LED photoherapyContinuous phototherapy for 24 h, for newborns placed incubators or radiant warmers will interrupted only for feeding and nursing for 20 - 30 min every three hours.

Timeline

Start date
2022-01-01
Primary completion
2022-08-01
Completion
2022-12-01
First posted
2022-02-25
Last updated
2022-02-25

Locations

1 site across 1 country: Armenia

Source: ClinicalTrials.gov record NCT05257369. Inclusion in this directory is not an endorsement.